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Abstract
Background: Dengue vaccines are now in late-stage development, and evaluation and robust estimates of dengue disease
burden are needed to facilitate further development and introduction. In Cambodia, the national dengue case-definition
only allows reporting of children less than 16 years of age, and little is known about dengue burden in rural areas and
among older persons. To estimate the true burden of dengue in the largest province of Cambodia, Kampong Cham, we
conducted community-based active dengue fever surveillance among the 0-to-19–year age group in rural villages and
urban areas during 2006–2008.
Methods and Findings: Active surveillance for febrile illness was conducted in 32 villages and 10 urban areas by mothers
trained to use digital thermometers combined with weekly home visits to identify persons with fever. An investigation team
visited families with febrile persons to obtain informed consent for participation in the follow-up study, which included
collection of personal data and blood specimens. Dengue-related febrile illness was defined using molecular and serological
testing of paired acute and convalescent blood samples. Over the three years of surveillance, 6,121 fever episodes were
identified with 736 laboratory-confirmed dengue virus (DENV) infections for incidences of 13.4–57.8/1,000 person-seasons.
Average incidence was highest among children less than 7 years of age (41.1/1,000 person-seasons) and lowest among the
16-to-19–year age group (11.3/1,000 person-seasons). The distribution of dengue was highly focal, with incidence rates in
villages and urban areas ranging from 1.5–211.5/1,000 person-seasons (median 36.5). During a DENV-3 outbreak in 2007,
rural areas were affected more than urban areas (incidence 71 vs. 17/1,000 person-seasons, p,0.001).
Conclusion: The large-scale active surveillance study for dengue fever in Cambodia found a higher disease incidence than
reported to the national surveillance system, particularly in preschool children and that disease incidence was high in both
rural and urban areas. It also confirmed the previously observed focal nature of dengue virus transmission.
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Introduction
Dengue remains a major public health problem in tropical and
sub-tropical countries despite aggressive efforts to control the
mosquito vector [1–3]. Every year, an estimated 50–100 million
cases of dengue fever occur and 250,000 to 500,000 cases of the
more severe form, dengue hemorrhagic fever (DHF), are reported
depending on epidemic activity [4]. However, the true incidence
of dengue fever is not known in most disease endemic countries.
Several dengue vaccine candidates have been developed and are
currently being tested in clinical trials [5,6]. Accurate estimates of
dengue disease burden based on robust estimates of disease
incidence will become an important factor in the public-health
decision making process for endemic countries regarding the use of
a safe and effective vaccine [7,8].
In Cambodia (estimated population: 14.4 million), dengue is
highly endemic and affects mainly children [9]. However, due to
limited resources, the National Dengue Control Program (NDCP),
which manages the national dengue reporting system, only accepts
reports of clinically diagnosed cases who are ,16 years of age and
have been hospitalized [9–11]. As a result, national incidence data
is thought to substantially underestimate the actual incidence of
dengue since most patients are not hospitalized [11,12]. Secondly,
inherent to the NDCP case definition, the burden of dengue in late
adolescence is unknown.
Historically, dengue has been considered a predominantly
urban disease of tropical countries [1], probably because many
early studies of dengue epidemiology were performed in urban
settings and observations that annual increases in mild and severe
disease incidence usually emanate from urban centers [1,13–15].
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rural and urban areas [16–18], to our knowledge no studies have
compared dengue incidence in contiguous rural and urban
settings.
Cambodia’s national data have indicated high dengue inci-
dences in both rural and urban districts [9]. To make a robust
estimate of the actual incidence of symptomatic dengue virus
(DENV) infection (i.e. dengue disease burden) in children and
adolescents living in rural and urban areas of Cambodia and to
describe other aspects of the epidemiology of dengue, we
conducted active, community-based fever surveillance combined
with diagnostic testing for DENV infection in the largest province
in Cambodia during 2006–2008.
Methods
Surveillance population
Active, community-based fever surveillance was conducted in
Kampong Cham (KC) province from 2006–2008 mostly during
May–November, which is the rainy season and associated with
increased vector activity. KC has the largest population in
Cambodia and is located 120–180 km east of Phnom Penh. The
provincial capital, KC town, has a population of approximately
90,000 (Figure 1) and a provincial hospital which has served as a
sentinel site for NDCP dengue surveillance. We selected a
convenience sample of villages from two rural districts located
within ,60 km radius of KC town and three districts within the
KC town urban area. The population density within the urban
area was estimated at ,1900 persons/km
2 and ,450 persons/
km
2 within the rural villages.
Surveillance design
Active surveillance was conducted by village teams (VT)
comprised of 2–3 volunteers from each respective village and five
investigation teams (IT), each comprised of a pediatric phlebot-
omist and an interviewer from the staff of the KC provincial
hospital. Members of the VT were on the village council and
selected with agreement of the respective village chiefs. VTs made
weekly home visits to identify persons with fever or history of fever
defined as an axillary temperature of $37.5uC in the previous
seven days. Each VT member was responsible for a village zone
and recorded home visits and temperatures in a census logbook. A
team from Institut Pasteur - Cambodia (IPC) monitored VT
performance on a weekly basis through unscheduled visits and
frequent telephone calls. When notified by the VT about a febrile
person, the IT visited the household to obtain written informed
consents to participate in the follow-up part of the study from the
patient or from one of the parents for children ,18 years of age;
children aged 12–17 years were also required to give verbal assent.
A first (acute) whole blood specimen was collected within seven
days of fever onset and a second (convalescent) sample was
obtained on day 10–14 after fever onset. Using a standardized case
report form (CRF), we collected data on demographics, illness
related symptoms, type of care sought for the fever episode and
duration of fever. Blood specimens were brought to KC Hospital
at 4uC in insulated boxes, separated into serum aliquots, which
were stored in liquid nitrogen and transported to IPC in Phnom
Penh twice weekly for subsequent serologic and molecular testing.
Over the three-year period, surveillance methods were modified
to expand the study. In 2006, we only enrolled subjects ,16 years
of age in 16 villages with documented fever $48 h measured using
mothers’ or VT’s thermometers, In 2007 and 2008, surveillance
was expanded to include persons ,20 years of age, and a digital
thermometer and a notebook to record temperatures was provided
to each household along with training on how to measure and
record axillary temperatures. For 2007–2008, fevers recorded by
the mother regardless of duration were reported to the VT for
study enrollment. During the entire study period, the IT provided
the mother or patient with one day treatment of paracetamol and
advice to seek medical care, but did not otherwise influence health
seeking behaviors.
Participation of the village in fever surveillance was an
independent decision of the respective village chiefs following a
formal presentation by the study investigators. Village chiefs gave
oral consent for village participation which in Cambodia is
required before villagers are allowed to consent individually. The
study protocol was annually reviewed and approved by the
National Ethics Committee for Health Research, Phnom Penh,
Cambodia and the Institutional Review Board of the International
Vaccine Institute, Seoul, Korea. Relevant attributes of our
observational study were reviewed using the STROBE checklist
(Checklist S1).
Case definition. A dengue case was defined as a febrile
person positive for anti-DENV IgM in the convalescent phase
serum. Subjects who tested positive for anti-DENV IgM on more
than one occasion during any year were only counted as one
dengue case if the second febrile episode and positive test occurred
within three months of the first positive episode. However, if the
second febrile, IgM anti-DENV positive episode was also DENV
positive by RT-PCR, that was classified as a second case of dengue
in the same person.
Laboratory testing
All acute and convalescent serum specimens were tested for
both anti-DENV IgM and anti-Japanese Encephalitis virus (JEV)
IgM using in-house capture enzyme-linked immunosorbent assays
(MAC-ELISA) as described by Rossi and Ksiazek [19] and
adapted for DENV and JEV diagnosis [20]. Briefly 96-well
microtiter plates were coated with goat anti-human IgM and
100 mL of serum samples and controls diluted 1:100 in phosphate
buffered saline + Tween 20 0.5% (PBS-T) +5% nonfat dried milk
(PBS-T-NDM) were added and incubated for one hour at 37uC.
After washing with PBS-T, DENV (DENV-1 Hawaii, DENV-2
New Guinea, DENV-3 H-87, DENV-4 H-241) or JEV (Na-
Author Summary
Dengue is a major public health problem in South-East
Asia. Several dengue vaccine candidates are now in late-
stage development and are being evaluated in clinical
trials. Accurate estimates of true dengue disease burden
will become an important factor in the public-health
decision-making process for endemic countries once safe
and effective vaccines become available. However, esti-
mates of the true disease incidence are difficult to make,
because national surveillance systems suffer from disease
under-recognition and reporting. Dengue is mainly report-
ed among children, and in some countries, such as
Cambodia, the national case definition only includes
hospitalized children. This study used active, community-
based surveillance of febrile illness coupled with laboratory
testing for DENV infection to identify cases of dengue
fever in rural and urban populations. We found a high
burden of dengue in young children and late adolescents
in both rural and urban communities at a magnitude
greater than previously described. The study also con-
firmed the previously observed focal nature of dengue
virus transmission.
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sucrose acetone extraction [21] was added to each well at a
concentration of 16 hemagglutination units, and incubated at 4uC
overnight. The plate was washed with PBS-T, monoclonal
antibody to the antigens being detected was added, incubated at
37uC, washed and peroxidase conjugated anti-mouse Fab H+L
was added. The final reaction was developed and read at 405 nm
on an automated plate reader. A result was considered positive
when the optical density (OD) was . mean OD of the three
negative control specimens + three standard deviations. When the
anti-JEV result was higher than the anti-DENV result the subject
was not considered to have DENV infection.
Only acute phase sera of participants who were positive for anti-
DENV IgM in the convalescent sample were tested for DENV
using molecular methods. DENV ribonucleic acid amplification,
detection and serotyping were performed using reverse transcrip-
tase polymerase chain reaction (RT-PCR) according to Lanciotti
[22] as modified by Reynes et al [23]. Briefly, RNA was extracted
from 140 mL of serum (QIAamp Viral RNA Mini kit, QIAGEN)
or from 200 mL of specimen (MagNA Pure Compact Nucleic Acid
Isolation Kit I, Roche Diagnostic) on a MagNA Pure Compact
instrument. First round RT-PCR was carried out in a 25-ml
volume containing 2.5 ml of extracted nucleic acid, 0.2 mM (each)
dNTPs, 5 X Taq buffer, 1 ml of Qiagen One-step RT-PCR kit,
0.2 mM each D1 and D2 outer primers [24], and PCR-grade
water with thermal-cycler (MyCycler, Bio-Rad) settings of 60 min
of reverse-transcription at 45uC, 2 min denaturation at 92uC
followed by 35 cycles consisting of 94uC for 30 sec, 55uC for
30 sec and 72uC for 1 min, and a 72uC final extension step for
10 min. Semi-nested PCR was performed in a 50-ml reaction
mixture containing 2.5 mM MgCl2, 0.2 mM (each) dNTPs, 10X
Taq buffer, 1.2 U of Taq polymerase, 5 ml of diluted first-round
PCR product diluted 1:100 and 0.2 mM (each) D1, TSI-modified,
TS2, TS3 and TS4 primers [23]. The cycling program consisted
of a 5-min denaturation step at 94uC, followed by 25 cycles each at
94uC for 30 sec, 55uC for 30 sec, and 72uC for 1 min, and ended
with 72uC extension for 10 min. Positive and negative controls
were included for each step of the process. Detection was by
agarose gel electrophoresis for the expected amplicon sizes.
Dengue virus isolation was attempted on all PCR positive
specimens using C6/36 (Aedes albopictus) and Vero E6 cells, with
detection by direct fluorescent microscopy with serotype-specific
monoclonal antibodies as previously described [24].
Data analysis
Proportions, rates, risk ratios (RR), odds ratios (OR), 95%
confidence intervals (CI) and statistical tests were calculated using
STATA version 9.2 (StataCorp, College Station, TX, USA).
Dengue incidences for the study periods, which encompassed the
dengue season, were not annualized; we assumed they represented
the annual incidence because of the marked seasonality of dengue.
We calculated incidence rates using person-weeks to illustrate time
series, accounting for the actual number of persons under
surveillance per week. In addition, to account for the length of
time during which the participants were followed up by age group,
we calculated age-specific incidence rates using person-season.
One person-season corresponded to one participant followed
during the entire surveillance period of the respective year. A child
was declared lost to follow-up when he/she was not present during
3 weekly home visits in a row. Logistic regression models were
Figure 1. Study sites and dengue incidences by site and year, Kampong Cham province, Cambodia, 2006–2008.
doi:10.1371/journal.pntd.0000903.g001
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dent predictors with p-to-enter of 0.10 or less.
Results
Characteristics of the surveillance population
Over the three years, 32 villages and 10 urban areas
participated in active surveillance for febrile illnesses; five villages
for three years, 13 for two years and 14 for one year. Thirty-four
percent of the population of these villages or urban areas were
covered by the surveillance study and ranged from 6.2–78.6% per
village or urban area. A total of 6,657 children aged ,16 years
from 16 villages were in the surveillance study during May 08-
November 23, 2006, while 10,086 and 7,673 individuals ,20
years of age were under surveillance during June 01-December 31,
2007 and April 01 to December 31, 2008, respectively (Table 1).
A total of 2,575 (25.5%) surveillance participants resided in urban
areas in 2007 and 1,024 (13.2%) in 2008. Over the study period,
52% were males and the median age of the participants was 6
years among the 0–15 year age group. No differences in gender
distribution were noted between years. The number of refusals to
participate in the study was 0.6% per year on average (range 0.4–
0.9%). Few participants (0.9% on average; range 0.8–1.1%)
moved outside the surveillance area (Table 1).
Characteristics of non-dengue and dengue cases
Over the study period, 6,121 febrile episodes were reported
from 4,995 individuals who were bled and tested for DENV
infection (data by year shown in Table 1). Of these febrile
episodes, 736 (12%) had a laboratory-confirmed DENV-infection
with 425 (58%) being confirmed by RT-PCR (Table 2). DENV
was isolated by cell culture in 292 (69%) of PCR-positive samples.
No dengue-related deaths were reported among the study
population. The median age of dengue cases was 7 years and
Table 1. Characteristics of participants in febrile illness surveillance study, Kampong Cham province, Cambodia, 2006–2008.
Year 2006 2007 2008
Rural villages & Urban areas (number) 16 & 0 20 & 5 20 & 5
Percentage of village populations covered by active surveillance
Median coverage 34.8% 36.4% 32.9%
Min-Max 12.8–69.8% 6.2–78.6% 11.0–48.4%
Active Fever surveillance
Surveillance period in days (in months) 199 (6) 214 (7) 275 (8)
No of participants (% urban population) 6,657 (0) 10,086 (25.5) 7,673 (13.2)
Median days of surveillance for each participant 195 210 259
Minimum - maximum (min - max) of surveillance 8–199 14–214 14–275
Number of refusals to participate (%) 37 (0.6) 44 (0.4) 68 (0.9)
Number of participants lost to follow-up (%) 76 (1.1) 91(0.9) 59 (0.8)
Males (%) 51.9 51.9 50.5
Age group distribution (%)
0–4 years 25.3 22.9 23.4
5–9 years 31.4 25.6 26.4
10–14 years 43.0* 29.2 29.5
15–19 years NA 22.4 20.8
Mean 8.1 9.5 9.4
Median (min–max) 8 (0–15) 10 (0–20) 10 (0–20)
Number of febrile episodes 1,633 3,088 2,851
Number of febrile episodes with blood samples (number of individuals) 444 (426) 2,953 (2,474) 2,724 (2,095)
- Fever events per person
Mean 1.15 1.22 1.34
Median (min–max) 1 (1–5) 1 (1–5) 1 (1–6)
Incidence rates of febrile illness per 1,000 person-seasons
- Overall 244.0 336.9 429.5
- Urban areas NA 176.1 164.9
- Rural areas 244.0 390.0 470.8
- By village
- Number of villages/areas with fever episodes 16 25 25
- Mean 196.5 381.4 436.8
- Median 193.0 315.0 414.8
- Min–max 31.5–368.1 137.5–1002.2 39.0–1018.1
*data pertaining to 10–15 year age group in 2006; NA: not available.
doi:10.1371/journal.pntd.0000903.t001
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detected yielding an incidence of 13.4/1,000 and 17.6/1,000
person-seasons, respectively. In 2007, a large epidemic occurred
with 530 dengue cases resulting in an incidence of 57.8/1,000
person-seasons. Over the three years, the majority of cases
occurred during May–August (86% on average). Only 3.9% of
dengue cases reported fever that lasted ,2 days. Significant
differences in the proportions of cases requiring hospitalization
were noted between years: 41.6%, 10.6% and 2.6% in 2006, 2007
and 2008 respectively (p,0.001) (Table 2). Over the three years,
among febrile patients, those with DENV-infection sought care
more often (52.7% versus 23.8%, p=,0.001) and were more
Table 2. Characteristics of dengue virus infected febrile patients, surveillance study villages, Kampong Cham province, Cambodia
2006–2008.
Year 2006 2007 2008
Number of dengue cases 89 530 117
Age in years
Mean 6.6 7.1 8.3
Median 6 6 8
Min–Max 0–15 0–19 1–17
Duration of fever
Number of cases (%)
Fever ,4 15 (16.9) 189 (35.7) 45 (38.5)
Fever =4 14 (15.7) 110 (20.8) 35 (29.9)
Fever .4 60 (67.4) 231 (43.6) 37 (31.6)
Patient outcomes
Number of cases (%) *
Hospitalized 41 (46.1) 56 (10.6) 3 (2.6)
Outpatient care 45 (50.5) 222 (41.9) 36 (30.8)
Did not seek care 3 (3.4) 252 (47.5) 78 (66.7)
Laboratory results:
Number (%)
Positive by RT-PCR 32 (35.9) 320 (60.4) 72 (61.5)
serum collected 0 – 4 days of fever onset 20/28 (71.4){ 217/262 (82.8) 56/65 (86.2)
serum collected .4 days of fever onset 12/61 (19.7) 103/268 (38.4) 16/52 (30.1)
Positive virus isolation 21 (23.6) 214 (40.4) 57 (48.9)
Dengue serotypes
Number (%)
DENV-1 25 (78.1) 90 (28.1) 0
DENV-2 2 (6.3) 1 (0.3) 56 (77.5)
DENV-3 5 (15.6) 217 (67.8) 12 (16.9)
DENV-4 0 12 (3.8) 4 (5.6)
Incidence rates of dengue fever per 1,000 person – seasons
- Overall 13.4 57.8 17.6
- By age group (years)
0–4 18.0 81.7 13.2
5–9 15.9 84.2 19.0
10–14 8.1** 40.2 13.7
15–19 NA*** 12.6 4.7
- Urban areas NA 17.1 21.2
- Rural areas 13.4 71.3 17.1
Dengue cases by village or urban area
- Number with $1 dengue case (%) 12 (75) 25 (100) 21 (84)
- Mean 16.2 68.2 25.1
- Median
(min–max)
6.5
(1.5–108.1)
36.5
(5.6–211.5)
16.9
(3.3–127.4)
*not mutually exclusive;
**data only available for ,16 year age group in 2006;
***NA: not available;
{serum collected 2–4 days of fever onset in 2006.
doi:10.1371/journal.pntd.0000903.t002
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those without DENV. Among persons with febrile illness, the
duration of fever was significantly longer among those with DENV
infection compared to those without DENV infection (4.4 days vs.
3.7 days, p,0.001) (Table 3). The duration of fever between the
0–9, 10–14 and 15–19 year-age groups was not significantly
different (4.5, 4.2 and 4.3 days respectively, p values.0.16).
Similarly, hospitalization rates among persons with dengue were
not significantly different between the 3 age-groups (29.3%, 9.3%
and 23.8% respectively, p values.0.15).
DENV transmission pattern
In 2006 and 2008, dengue cases occurred in 12 (75%) and 19
(76%) of villages respectively (among affected villages, median 1
case per village in both years). The patterns of dengue by village
varied considerably from year to year. During the 2007 epidemic,
all villages were affected by dengue: median incidence rate by
village was 36.5/1,000 person-seasons (range by village 5.6–
211.5/1,000) including eight (32%) villages with incidence rates
$100/1,000 person-seasons. Highest incidence rates by village
observed in 2008 and 2006 were 127.4/1,000 and 108.1/1,000
person-seasons respectively. The incidence in rural areas in 2007
was 4.2-times higher than that in urban areas (71.3 versus 17.1/
1,000 person-seasons, p,0.001). The following year, the relative
risk reversed. The risk ratio was 0.81 when rural with urban areas
(17.1/1,000 vs. 21.2/1,000 person-seasons; p=0.01) (Figure 2).
Highest age-specific incidence rates were observed among the
0–4 and 5–9 year age-groups and tended to be 2–3 times higher
than that of the 15–19 year-olds (Table 2). Peak ages of dengue
by year are shown in Figure 3 with children aged 3, 6, and 7
comprising the highest incidence in 2006, 2007, and 2008,
respectively.
DENV-serotype distribution and associations with
frequency of hospitalization
All four serotypes were identified over the study period, but
DENV-3 (n=234, 55.3%) and DENV-1 (n=115, 27.2%)
accounted for most (Table 4). In 2006, DENV-1 accounted for
78% of the cases that were PCR positive (25/32), was mainly
found in one village (18 of 19 PCR positive cases) and was
associated with a large outbreak (59 cases; incidence rate 108.1/
1,000 person-seasons during 11 weeks). Of these 18 DENV-1 cases
in the village, 8 (44.4%) were hospitalized and significantly
younger than non-hospitalized children with DENV infection
(mean age 5.3 [age range 0.3–12] versus 7.3 years [age range 0.8–
15] respectively, p=0.043). DENV-3 (67.8% of cases) was
associated with the 2007 epidemic and was replaced by DENV-
2 (77.5% of cases) in 2008 (Table 2). Co-infection with DENV-1
and -3 was observed in 2 patients. Patients with DENV-4 (n=16)
were rare and of these, 8 (50%) patients resided in one village in
2007.
DENV-1 or DENV-3 infection presented with fever duration
that was longer when compared to DENV-2: 53.9% of DENV-1
and 48.7% of DENV-3 infected subjects had fevers lasting .4
days versus 25.9% of DENV-2 (p values#0.05, Table 4).
Interestingly, of DENV-2 infected patients none was admitted to
hospital compared to 11.3–14.5% for DENV-1, -3 or -4.
Multivariate analyses performed comparing DENV-1 and -2;
DENV-1 and DENV-3, and DENV-2 and -3 retained an
independent association between DENV-2 and shorter fever
duration when compared with DENV-1 (p=0.050) and -3
(p=0.011). Furthermore, DENV-2 infection was more often
observed in older children when compared to DENV-3 infection
(p=0.009, Table 4). Hospitalization was more frequently
associated with DENV-3 infections compared with DENV-1
Table 3. Variables associated dengue virus infection among persons with febrile illness compared with non-dengue febrile illness,
Kampong Cham province, Cambodia, 2006–2008.
TOTAL DENGUE Non DENGUE P value RR** 95%CI**
n=6121 % n=736 % n=5385 %
Age in years
Mean 7.1 - 7.2 - 7 - 0.651
M e d i a n 7- 7 - 7-
Min–Max 0–19 - 0–19 - 0–19 -
Gender
Males 3,132 51.4 372 53.6 2,760 53.1 0.767
Duration of fever in days
Mean 3.80 - 4.41 - 3.71 - ,0.001
M e d i a n 4- 4 - 4-
Min–Max 0–20 - 0–18 - 0–20 -
Fever resulting in care seeking 1,701 27.2 388 52.7 1,313 23.8 ,0.001 2.1 1.9–2.4
Care at:
Pharmacy 321 5.1 34 4.6 287 5.2 0.405 0.9 0.6–1.2
Health center 191 3.1 27 3.7 164 3.0 0.372 1.2 0.8–1.8
Private clinic 997 16.3 236 32.1 761 13.8 ,0.001 2.2 1.9–2.6
Hospitalization 191 3.1 106 13.6 91 1.6 ,0.001 8.0 6.0–10.8
**RR = risk ratio; 95% CI = confidence interval.
doi:10.1371/journal.pntd.0000903.t003
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when considering only year 2007, DENV-3 infection was also
associated with higher frequency of hospitalization when com-
pared with DENV-1 (15.7% (34/216) vs. 4.4% (4/90), p=0.006).
Discussion
Assessments of transmission patterns and true incidences of
dengue or DENV-infections are resource intensive and have been
performed in a limited number of settings. Multi-year studies with
active, community-based surveillance for febrile illness have been
conducted in South East Asia (Kamphaeng Phet [25] and
Ratchaburi, Thailand [26], A Sabchareon, personal communica-
tion, unpublished data); Long Xuen, Viet Nam [27] and Bandung,
West Java, Indonesia [28] and in the Americas (Iquitos, Peru [29]
and Managua, Nicaragua [30,31]). Only one study determined the
incidence of dengue among adults (18–66 year-old factory
workers) in Indonesia [28]. All the others determined disease
incidence in children using various active surveillance methods to
detect febrile illness, including school absenteeism and self-
reporting by participants. All studies included clinical follow-up
to identify patients for serologic and molecular testing for DENV
infection. Similar to our study, surveillance was mainly conducted
during the dengue season in Kamphaeng Phet Thailand), while
sites in Ratchaburi, Thailand, Vietnam, Nicaragua, Peru and
Indonesia conducted year-round surveillance. However, all these
studies only conducted surveillance in relatively populated urban
or semi-urban areas. In addition, community-based active
surveillance for febrile illness in all age groups was conducted
during several large dengue epidemics in rural and urban areas of
Cuba in 1997 and 2001 [32,33] although only surveillance data
from urban areas were published.
Although there were some methodological differences in how
active surveillance was conducted in our study and those identified
above (e.g., house-to-house visits compared to school absenteeism
or self-identification of fever episodes), we found annual disease
incidence rates of 1.3–5.7% over three years, which was higher
than those observed in Kamphaeng Phet (0.8–3.6% in 4–14 year-
olds) or Ratchaburi, Thailand (1.6% in 4–14 year-olds) (26),
Nicaragua (0.4–1.9% in 2–11 year-olds), Vietnam (1.7–4.0%
among 2–15 year-olds) or Peru (1.0% in 5–17 year-olds).
Moreover our highest incidence rates were among pre-school
children ages compared to Thailand and the Americas where the
highest age-specific incidence rates were among children .8–9
years of age [25,31].
For several reasons the incidence observed in our study may still
have underestimated the true disease burden although our use of
house-to-house case finding was most likely to identify febrile
children in a low-literacy rate population where attendance at
public health centers is thought to be low [34,35]. First,
surveillance was not performed throughout the year and dengue
cases are known to occur at low rates between dengue seasons.
However, based on nationally reported cases, those that occur
during the non-dengue season only account for ,5% of the total
[9]. Second, in the first year of the study (2006) our case definition
required a fever $48 hrs and only a third of children with a febrile
episode met those criteria. However it is unlikely that a significant
number of cases were excluded since in subsequent years ,4% of
dengue cases had fever duration ,2 days. Third, in 2007 a large
Figure 2. Incidence of Febrile Illness and Dengue Fever by Week, Kampong Cham Province, Cambodia, 2006–2008.
doi:10.1371/journal.pntd.0000903.g002
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doi:10.1371/journal.pntd.0000903.g003
Table 4. Characteristics associated with serotypes, Kampong Cham province, Cambodia, 2006–2008.
DENV-1 DENV-2 DENV-3 DENV-4
All confirmed
cases DENV-1 vs. -2 DENV-1 vs. -3 DENV-2 vs. -3
n=115 n=58 n=234 n=16 n=736 aOR** p value aOR p value aOR p value
Duration of fever in days:
,4 31.3 43.1 28.2 56.3 18.5 ref.* ref. ref.
=4 14.8 31.0 23.1 18.8 12.5 1.7 0.279 1.8 0.105 1.0 0.935
.4 53.9 25.9 48.7 25.0 26.5 0.4 0.050 1.2 0.588 2.7 0.011
Patient outcomes (%)
Hospitalized 7.8 0.0 14.5 12.4 10.8 3.1 0.045
Non-inpatient care‘ 54.8 41.4 38.6 31.3 42.8
Did not seek care 37.4 58.6 46.9 56.3 42.4
Age distribution in years (%)
0–4 30.4 25.9 37.2 18.8 33.1 ref. ref. ref.
5–9 41.7 36.2 41.5 50.0 41.1 1.0 0.982 0.8 0.508 0.8 0.522
10–14 24.3 34.5 17.1 18.8 21.5 1.9 0.187 0.7 0.299 0.4 0.009
$15 3.5 3.4 4.3 12.5{ 4.3 1.7 0.512 1.0 0.980 1.1 0.935
*ref. = reference group;
**aOR = adjusted Odds Ratio using logistic regression model, which included age, fever duration and patient outcomes as independent variables.
‘ pharmacy, outpatient clinic, etc.
{DENV-4 was not significantly more frequent in the 15–19 age group compared with other serotypes (p.0.30).
doi:10.1371/journal.pntd.0000903.t004
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increase of cases reported to NDCP as compared to the previous 5
years [9]. Since the NDCP data indicated that the epidemic in
2007 started in Cambodia approximately one month before our
surveillance began and accounted for ,25% of the total reported
cases [9]; we may have missed this proportion of cases prior to our
start of active fever surveillance in June. Finally, our laboratory
diagnostic algorithm only tested acute phase samples from patients
with fever when the convalescent sample tested positive for anti-
DENV IgM. In a setting such as ours where there is a high
frequency of secondary DENV infections, up to 28% of secondary
infections might not be detected serologically because of low IgM
levels [36].
Dengue is highly focal in its geographic distribution and this was
observed during this surveillance study. Dengue incidences by
village showed wide ranges and a markedly diverse spatial
distribution within the study area and population. DENV-3
predominated in 2006 in Cambodia and was reported in 16 of 24
provinces in Cambodia (Ministry of Health’s unpublished data).
However, during the same year an outbreak in one of the
participating villages was caused by DENV-1 and was responsible
for two-thirds of all identified cases in the study area. In 2008, one
village was affected by DENV-2 with an attack rate of ,13% and
accounted for 34% of all identified cases. A wide range of
incidences among the villages and urban areas was also observed
during the 2007-epidemic.
Another finding in this surveillance study was that rural areas
were usually affected by dengue to the same degree as urban areas
or, as during the 2007-epidemic, at even higher attack rates.
Factors thought to explain the perceived urban predominance of
dengue included rapid human population growth, the presence of
an unreliable or absent water supply which forced residents to
store water in open containers and the presence of other man-
made containers, all of which serve as major production sites for
Aedes aegypti [35,37,38] All of these conditions are present in rural
areas of Cambodia as the country develops without proper water
supplies and persons from rural areas frequently travel between
large cities and relatives in their villages. The villages in our
surveillance study were located close to one of the main national
roads with constant daily traffic between villages and Phnom Penh
and the opportunity for dengue introduction from viremic
individuals passing through the area. The expansion of dengue
to rural areas has also been observed in Thailand and India [16–
18]. In the absence of a dengue vaccine, this finding underscores
the importance of conducting education and vector control
programs in rural as well as urban areas of Cambodia. The high
dengue incidence in children ,7 years of age who rarely leave the
villages and are not yet in school, argues for ongoing transmission
within Cambodian villages and around households as has been
recently observed in Thailand [39].
Assuming that hospitalization was a surrogate for disease
severity, 2006 appeared to have been particularly severe with
46% of dengue cases hospitalized. However, our study area may
not have been representative of the country. A DENV-1-related
outbreak occurred primarily in one village in the study area and
resulted in a higher hospitalization frequency among younger
children, while the predominant virus circulating in the country
was DENV-3. Because DENV-1 has circulated less frequently
than DENV-2 or DENV-3 in Cambodia [9], it may have caused
more severe disease expression among a largely susceptible
population. In subsequent years, DENV-4 and DENV-2 appeared
to have been associated with milder disease than DENV -1 and
DENV-3. Less severe disease expression has been previously
described for DENV-4, however, milder expression of DENV-2
dengue came as a surprise since this serotype was associated in
previous studies from Thailand with increased disease severity
[40,41]. Nevertheless, clinical expression may also depend on
genetic sub-strains within the four serotypes, pre-existing antibody
to DENV or the sequence of infections with other serotypes [42].
This phenomenon of apparent attenuation of dengue disease
severity at a population level was also seen observed after the large
epidemics of 1998 in the Philippines and Thailand [43,44]. We
were limited in further analyses since circulation of serotypes was
year-dependent: only 5% of DENV-2 detected in this study
circulated in 2006 and 2007 and no DENV-1 was identified in
2008.
Our surveillance study highlights once again the high degree of
under-recognition and under-reporting of this disease and the
variation in dengue epidemiology which occurs annually because
of the cyclical variation in incidence. A number of factors are
thought to influence DENV transmission and disease expression
such as environment [45], human and vector behaviors [46],
possible virulence of the virus strains [13,42,43], and the human
host [42,47,48] (baseline immunity and cross-protective immuni-
ty). Given the cyclical nature of dengue incidence with broad
variations from one year to another, we underscore the
importance of maintaining long term population-based surveil-
lance sites to better estimate true incidence and define the
dynamics of dengue epidemiology and serotype circulation. Long-
term epidemiological data on dengue and DENV transmission
obtained though population-based surveillance studies will also be
needed to for evaluation of promising dengue vaccine candidates
both through randomized, controlled clinical trials of efficacy [49]
and studies of vaccine effectiveness.
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